Rfa
Rfa funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
NIH RFA-DA-25-060: High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
NIH NIDA RM1 funding for interdisciplinary teams studying HIV and substance use, prioritizing ambitious team-based proposals with a single transformative goal and up to five years of support.
NIH RFA-NS-26-001: Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
This NIH opportunity funds research that uses expanded-access data from investigational ALS treatments to support studies in patient populations that cannot enter ongoing clinical trials, with $40,000,000 in FY 2026/27 program funding and a four-award cap for the cycle.
RFA-AI-27-016: Tuberculosis Research Advancement Centers (TRACs) (P30, Clinical Trial Not Allowed)
Historical NIH/NIAID center-grant opportunity for Tuberculosis Research Advancement Centers. The 2026 cycle closed on July 10, 2026; no subsequent cycle is announced on the official record checked.
RFA-DA-26-034: Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on the Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic Opioids
NIH Trans-NIH RFA supports basic and applied research on acute exposure effects and delayed effects of ultra-potent synthetic opioids, with recurring R01 due dates in 2026 and 2027.
RFA-DA-27-004: BRAIN Initiative Theories, Models and Methods (R01, No Clinical Trials)
A 2026/2027 NIH BRAIN Initiative NOFO that funds computational, statistical, and data science tool development for analyzing complex multi-scale neural data with up to 15 awards per year from a $6M annual set-aside.
RFA-DC-25-005: In Vivo High-Resolution Imaging for Inner Ear Visualization (R01, Clinical Trial Optional)
This NIH NIDCD R01 NOFO supports higher-resolution structural or functional imaging for the living human inner ear, including eligible low-risk clinical trials, with a per-grant direct-cost limit and a five-year maximum project period.
RFA-DC-26-001: Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
NIH's NIDCD reissue supports early-stage dissemination and implementation (D&I) research that prepares evidence-based communication-disorder interventions for real-world use through a two-year, R21-format mechanism. The next listed application deadline is June 17, 2027.
RFA-DE-27-002: Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed)
NIH Notice of Funding Opportunity for one U24 Resource Center and associated Interdisciplinary Translational Projects to advance tissue engineering and regenerative medicine products through preclinical development toward clinical adoption.
RFA-HG-25-009: Supporting Talented Early Career Researchers in Genomics (R01)
NIH/NHGRI reissues an R01-style NOFO for highly promising Early Stage Investigators (ESIs) building independent genomics programs, with a maximum direct-cost budget of $400,000 per year and up to a five-year project term.
RFA-MH-26-170: BRAIN Initiative - Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01)
NIH BRAIN Initiative reissue NOFO for R01 projects that develop and validate high-impact tools for precise, cell- and circuit-specific neuroscience research without clinical trials.